General Information of the Compound
| Compound ID |
CP0159615
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3,4-dimethoxyphenyl)-4-{pyrazolo[1,5-a]pyridazin-3-yl}pyrimidin-2-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
AC1O6ZJ2
BDBM8134
CHEMBL186054
N-(3,4-dimethoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine
PYRAZOLOPYRIDAZINE 2
pyrazolo[1,5-b]pyridazine deriv. 25
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H16N6O2
|
||||||||||||||||||
| Molecular Weight |
348.366
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(Nc2nccc(n2)-c2cnn3ncccc23)cc1OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H16N6O2/c1-25-16-6-5-12(10-17(16)26-2)22-18-19-9-7-14(23-18)13-11-21-24-15(13)4-3-8-20-24/h3-11H,1-2H3,(H,19,22,23)
Show/Hide
|
||||||||||||||||||
| InChIKey |
AGAYQQLAAVQQLA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03643, Glycogen synthase kinase-3 beta
Protein ID: PT00962, Glycogen synthase kinase-3 beta
Clinical Information about the Compound